Castle Creek Pharma
is a biopharmaceutical company that discovers, develops and commercializes therapeutics for patients with rare skin diseases... Read moreCastle Creek Pharma
is a biopharmaceutical company that discovers, develops and commercializes therapeutics for patients with rare skin diseases... Read more
News
Dec 16, 2019
firstwordpharma
Castle Creek Pharma: Castle Creek Pharmaceutical Holdings Completes Acquisition of Fibrocell Science
Sep 17, 2019
Vista Today
Castle Creek Pharma: Pharma Firm in New Jersey to Buy Exton-Based Biotechnology Company for $63.3 Million
Sep 13, 2019
The Business Journals: Philadelphia
Castle Creek Pharma: Exton gene and cell therapy company to be sold in $63.3M deal
Sep 13, 2019
The Pharma Letter
Castle Creek Pharma: Castle Creek Pharma to acquire Fibrocell
Apr 15, 2019
BioPortfolio
Castle Creek Pharma: Fibrocell inks deal with Castle Creek worth up to $135 million to jointly develop FCX007 gene therapy httpsfirstwordpharma.comnode1635188tsid28®ionid6Â
Apr 15, 2019
Benzinga
Castle Creek Pharma: Fibrocell Strikes Funding Deal For Gene Therapy Candidate
Aug 11, 2018
Pharmabiz
Castle Creek Pharma: US FDA grants fast track status to Castle Creek Pharma's CCP─020 for EBS treatment
Aug 09, 2018
StreetInsider
Press Release: Castle Creek Pharma : Castle Creek Pharmaceuticals Receives FDA Fast Track Designation for Diacerein 1% Ointment for Treatment of Epidermolysis Bullosa Simplex
May 21, 2018
Pharmaceutical Processing
Castle Creek Pharma: FDA Grants Rare Pediatric Disease Designation For Treatment Of Debilitating Skin Disorder
May 17, 2018
M2 PressWIRE
Press Release: Castle Creek Pharma : Castle Creek wins US FDA's rare pediatric disease designation for diacerein 1% ointment for epidermolysis bullosa
Castle Creek Pharma Competitors
1
2
3
4
5
6
7
8
9
10